Menu

Press Releases and Bulletins

For more information on these press releases, contact: 

J. Benjamin Younger Office of Public Affairs
409 12th Street SW, Suite 602
Washington, DC 20024-2188
Tel: (202) 863-2494/Fax: (202) 484-4039 

Statement from the ASRM COVID-19 Task Force

For over a year, we have been working to evaluate the latest science around COVID-19 and reproductive health.

As scientists and medical experts conduct and analyze the research, we have refined our recommendations accordingly. As in all our work, we endeavor to help professionals and patients understand the best information available.

ASRM Applauds Administration Decision to Continue Fetal Tissue Research

The American Society for Reproductive Medicine (ASRM) applauds the decision from the National Institutes of Health (NIH)to continue to allow federally funded researchers to work with tissues and cell lines originally derived from fetal tissue. As we have seen with the development of the COVID-19 vaccines and therapeutics, the impact of these materials as research tools is broad, and essential.

Ricardo Azziz to step down as ASRM CEO; longtime COO Vickie Gamble to serve as interim CEO through 2021

Hugh Taylor MD, President of the American Society for Reproductive Medicine, today announced the resignation of CEO Ricardo Azziz MD, MBA, MPH effective June 30, 2021. Vickie Gamble, ASRM’s long-term Chief Operating Officer, will serve as interim CEO through the remainder of 2021. “We want to thank Dr. Azziz for his skillful leadership during what was certainly one of the most challenging times in our 77-year history”, said Dr. Taylor. “When searching for a CEO in 2019, we did not have “…ability to manage during a global pandemic” in the job description, but that is exactly what Dr. Azziz has had to do.” Dr. Azziz, remarked, “It has been my great honor leading the ASRM, an organization for which I have great respect, during these trying times, all with the goal of making the ASRM a stronger, more sustainable, and more relevant organization.”

Embryo Transfer Simulator Provides Fellows Practice for over 120 Simulated Transfers and Increases Physician Self-Confidence By 125%

The American Society for Reproductive Medicine (ASRM) announced today that embryo transfer simulation produced a 125% increase in physician self-confidence. As part of a two-day education course, fellows practiced more than 20 simulated embryo transfers, better equipping them to be confident and competent in the clinical environment. This finding is published in ASRM’s journal, Fertility and Sterility.

More than 77 Thousand Babies Born from ART

The Society for Assisted Reproductive Technology, the United States’ primary organization of professionals dedicated to the practice of assisted reproductive technologies (ART) is releasing its latest national and clinic-specific ART data, today. The preliminary national data set for 2019 shows 77,256 babies born resulting from 302,998 cycles performed during that year, an increase from the previous year’s number of 74,590 babies born from 279,288 cycles. 361 SART member clinics contributed to the report.

ASRM COVID-19 Task Force Issues Update No. 14

In the current update, the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to support both vaccination with currently available vaccines for all individuals, including women who are either pregnant or contemplating conception (see Update #11), and continued strict adherence to its earlier recommended mitigation strategies for disease prevention, including use of social distancing, and rigorous attention to hand washing, Personal Protective Equipment (PPE), especially masking, and quarantines when appropriate (see Update #3). In addition, the Task Force is issuing this update to assist reproductive care specialists in counseling their patients and their communities regarding vaccination, including vaccination in pregnancy, and to provide considerations for relaxing restrictions.

ASRM Ethics Committee Chair Co-Authors Science Article - Argues to Revisit the “14-Day Limit” on Human Embryo Research

Sigal Klipstein, MD, Chair of the ASRM Ethics Committee, co-authored an article appearing in the most recent issue of Science. The article entitled, “Human embryo research beyond the primitive streak,” explores the question of whether it is time to rethink the historical prohibition, now 40 years old, of culturing human embryos for research beyond 14 days consecutive or growth, or beyond the development of the primitive streak.

Update No. 13 – Variants, Vaccines, and Vaccination

Even though the decreasing trend in infection rates is encouraging, and 52 million in the U.S. have been vaccinated, CDC guidelines should be strictly followed, and COVID-19 prevention should remain a top priority to reduce the likelihood of the emergence of additional, new SARS-CoV-2 variants. While COVID-19 vaccines are highly effective in preventing illness and hospitalization, their effectiveness for prevention of transmission remains unclear. Care centers should continue to maintain usage of masks and double masking, hand washing, avoidance of crowds, and social distancing.

Update No. 12-Testing and Vaccine Truths: ASRM Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic

The Task Force is issuing this update to assist reproductive care specialists in counseling their patients and their communities regarding the long-term effects of having suffered COVID-19, the new variants of SARS-Cov-2 being reported, truths about use of testing and vaccines for SARS-CoV-2, when to consider performing surgery after a COVID-19 diagnosis, and information regarding vaccine hesitancy and pandemic-related stress.

HHS and CMS Issue Final Anti-Kickback Statute and Stark Law Final Rules

On December 2, 2020, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) and the Centers for Medicare and Medicaid Services (CMS) published final rules as part of the HHS Regulatory Sprint to Coordinated Care, which examined federal regulations with potential to impede healthcare providers' efforts to advance the transition to value-based care and improve the coordination of patient care across settings in federal healthcare programs and the commercial sector.

ASRM COVID-19 Task Force Releases Update #10 to Recommendations

The current update by the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to affirm the recommendations presented in Update No. 3 (American Society for Reproductive Medicine Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic - Update No. 3, April 24, 2020), which were further elaborated upon in Updates No. 4-9. Collectively, these updates recommend the judicious resumption of the delivery of reproductive care, with the use of careful preventive measures, such as the use of Personal Protective Equipment (PPE), including masks, frequent hand washing, and social distancing measures. Given the continued presence, and more recently the marked upsurge, of COVID-19 cases in much of the United States (U.S.), these strategies continue to be critical in managing this ongoing pandemic.

New Research Using Data from SART Patient Predictor Tool Assesses the Probability of Live Birth with One or More Cycles of Assisted Reproductive Therapy

Presenting their results at this year’s ASRM Scientific Congress, researchers using data analyzed from the Society for Assisted Reproductive Technology's (SART) Patient Predictor developed prediction models that estimate the cumulative probability of live birth over three complete cycles of in vitro fertilization (IVF).

ASRM Members to be Recognized for Work on Behalf of Patients and Families

ASRM is proud to acknowledge the Cade Foundation’s recognition of ASRM members, Dr. Michael Thomas, ASRM Vice President; Dr. Arthur Sagoskin, ; and Dr. Louis Weckstein, as Family Building Champions. ASRM also is pleased to note RESOLVE: The National Infertility Association’s recognition of ASRM member, Dr. Serena Chen, for her outstanding advocacy work for the infertility community. 

New ONC/CMS Rules to Impact Access to Electronic Health Information, Patient Access to Data

The Office of the National Coordinator for Health Information Technology (ONC) has released a final rule implementing provisions of the 21st Century Cures Act (Cures) related to electronic health information blocking, interoperability and the ONC Health IT Certification Program (Cert Program). The Centers for Medicare & Medicaid Services (CMS) also issued a final rule on patient access to data and interoperability.  

ASRM Announces Hugh Taylor, MD as New President

Washington, DC- The American Society for Reproductive Medicine is proud to announce Hugh Taylor, MD, of Yale University as our new president. Dr. Taylor is the Anita O'Keeffe Young Professor and Chair of the Department of Obstetrics Gynecology and Reproductive Sciences at Yale School of Medicine and Chief of Obstetrics and Gynecology at Yale-New Haven Hospital. He is also Professor of Molecular, Cellular and Developmental biology at Yale University. His clinical interests include IVF, infertility, endometriosis, implantation, menopause, uterine anomalies and Asherman's syndrome.

Better obstetric and neonatal outcomes result when gestational carriers come from agencies that follow ASRM guidelines

Washington, DC- Research presented at this year’s Scientific Congress shows that one in four gestational carrier pregnancies in a cohort of 194 did not meet ASRM guidelines. Guidelines are less likely to be followed when a gestational carrier is found through means other than an agency. In this study, 76% of carrier pregnancies were mediated through a surrogacy agency. Non-adherence to these guidelines was associated with an almost 5-fold increase in odds of spontaneous abortion. The most common violated ASRM criteria included women with BMI >35 and age (mostly >45 or <21).

Most patients resumed IVF treatment during the COVID-19 pandemic shut-down immediately when able

Washington, D.C.- Research presented at the 2020 Scientific Congress indicates that out of a total of 145 patients planning frozen embryo transfer (FET) and 133 patients planning a fresh cycle, 62% of all patients desired to initiate treatment once COVID-19 restrictions had been eased in May 2020. Among the fresh cycles, there was a trend towards older-age women being more prevalent among those who moved forward. FET cycles using a gestational carrier were more likely to continue delaying treatment.

Telehealth enables physicians to address a broad spectrum of diagnoses related to male infertility

Washington, D.C.- Researchers from Michigan Medicine in Ann Arbor have found that video visits can be used effectively with established patients to manage a broad spectrum of diagnoses that contribute to male infertility. In this study, 70 video visits between August 21, 2017 to March 17, 2020 were completed by 56 men at the median age of 36 (age 32 - 40); 78.5% were white, and most patients were referred by their primary care provider or their partner’s reproductive endocrinologist (47% and 33%, respectively). Most men were diagnosed with endocrinologic (29%) or anatomic (21%) contributors to infertility (see Table1A in abstract for full diagnostic categories).  

Women with PCOS are prone to sleep disorder leading to risk of anxiety and depression

Washington, DC- Women with polycystic ovary syndrome (PCOS) have been shown to be at risk for obstructive sleep apnea (OSA), which has been linked to depression and anxiety within the general population. That finding comes from researchers from the University of California, San Francisco School of Medicine, who gave women diagnosed with PCOS and being treated at their clinic from 2017 to 2020 a questionnaire to assess for OSA, depression, and anxiety symptoms.  

Income level and education do not have an impact on long-term reproductive outcomes for couples undergoing infertility care

Washington, D.C.- Researchers presenting at this year’s 2020 Scientific Congress have found that socioeconomic status does not negatively impact long-term outcomes in infertile couples seeking to expand their families. In this long-term follow-up of the randomized controlled trial, a survey was administered to couples who were enrolled in the Fast Track and Treatment Trial (FASTT), which investigated time to conception of conventional treatment for unexplained infertility versus a fast track approach in women ages 21-39 years. 

When the economy is down and unemployment is up, many couples are unable to access fertility care to expand families

Washington, D.C.- To better understand the impact the COVID-19 pandemic and resulting recession may be having on demand for fertility services in the US, researchers from Harvard Medical School/Boston Children’s Hospital and Extend Fertility in New York City recently studied the 2008 economic crisis’s effect on such services. The findings revealed a direct connection between unemployment and fertility care access.

Women with polycystic ovary syndrome are at increased risk of experiencing delivery-related child birth complications and cardiovascular disease after menopause

Washington, D.C.- A population-based study of 9.1 million births from 2004 to 2014 found that women with the hormonal disorder polycystic ovary syndrome (PCOS) are at an increased risk of experiencing delivery-related complications, including cesarean delivery, infections, and giving birth to a child with congenital anomalies.  

ASRM COVID-19 Task Force Releases Update #9 to Recommendations

The current update by the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to affirm the recommendations presented in Update No. 3 (American Society for Reproductive Medicine Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic - Update No. 3, April 24, 2020), which were further elaborated upon in Update Nos. 4-8. Collectively, these updates recommend the judicious resumption of the delivery of reproductive care, with the use of careful preventive measures, such as the use of Personal Protective Equipment (PPE), including masks, frequent hand washing, and social distancing measures. Given the continued presence of COVID-19 cases in much of the United States (U.S.), these strategies continue to be critical in managing this ongoing pandemic.

Update #8: American Society for Reproductive Medicine (ASRM) Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic

The current update by the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) continues to affirm the recommendations presented in Update No. 3 (American Society for Reproductive Medicine Patient Management and Clinical Recommendations during the Coronavirus (COVID-19) Pandemic - Update No. 3, April 24, 2020), which were further elaborated upon in Update Nos. 4-7. Collectively, these updates recommend the judicious resumption of the delivery of reproductive care. Given the continued presence of COVID-19 cases in much of the United States (U.S.), these strategies continue to be critical in managing this ongoing pandemic.

ASRM Task Force Announces Plans for Diversity, Equity and Inclusion in Reproductive Medicine

The Task Force will provide recommendations to the ASRM President, Board of Directors (BOD), and CEO regarding enhancing opportunities to increase and support diversity and equity, and inclusion of underrepresented minority populations, in the profession and leadership of reproductive medicine; and reducing, with the goal of eventually eliminating, health disparities in access and outcomes to reproductive care.

ASRM Pens Open Letter Defending Public Health Agencies and Experts

Washington, DC- Today The American Society for Reproductive Medicine, concerned about growing attacks on public health agencies from politicians, released an open letter urging that those agencies and the experts who work for them be listened to rather than attacked. Politicians seem determined to punish these experts for their knowledge and the data they collect instead of following their sound advice. The text of the letter is below. 

ASRM Opposes Supreme Court Decision on Contraception

As the voice of America’s reproductive medical professionals, we are disheartened by today’s decision from the Supreme Court, which allows a woman’s employer to single out contraception as a healthcare benefit they do not offer. The original terms of the Affordable Care Act allowed for reasonable accommodation of religious views. However, the Trump administration, and now the Supreme Court, have chosen to allow any employer for any reason to claim a religious exemption to contraceptive coverage.

American Society for Reproductive Medicine Applauds Supreme Court Abortion Decision

The American Society for Reproductive Medicine (ASRM) applauds today’s decision by the Supreme Court to uphold its binding ruling from Whole Women’s Health v. Hellerstedt. In the ruling, the Supreme Court said the law mandating that doctors who perform abortions have admitting privileges at nearby hospitals, was unconstitutional. The decision appropriately recognizes the impact of access to abortion and is a victory for reproductive justice and gender equality in America.

NIH Addresses COVID-19 Challenges - Launches RADx Initiative

Before the nation can safely return to business as usual, it is essential to develop and deliver effective and reliable COVID-19 testing and then implement it widely so that it is available to everyone. NIH is rising to this challenge through its Rapid Acceleration of Diagnostics (RADx) Initiative — a national call for scientists and organizations to advance their innovative ideas for new COVID-19 testing approaches and strategies.

American Society for Reproductive Medicine Recognizes Juneteenth as Holiday

Juneteenth commemorates June 19, 1865, when Union General Gordon Granger read federal orders in Galveston, Texas, that all previously enslaved people in Texas were free. Although the Emancipation Proclamation had formally freed them almost two and a half years earlier, Texas was the most remote of the slave states, so enforcement of the proclamation was slow to take effect. In light of recent tragic events and the need to recognize the culture of systemic racism in our nation, ASRM offices will be closed tomorrow.

SART Releases Podcast Series for Those Trying to Build a Family

The Society for Assisted Reproductive Technology (SART), is pleased to announce the release of its Fertility Experts Podcast Series. For those with questions about fertility and infertility, each 25-minute episode offers the insights of a variety of accomplished fertility specialists. They address a range of topics related to fertility testing, treatment, and the challenges of building a family.

ASRM Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic: Update #5

The world has been suffering a pandemic of a proportion not previously experienced in this century, with higher infectivity and mortality than previous epidemics. While acknowledging that infertility is a serious disease that requires treatment in a timely manner, in its recommendations of March 17, 2020 and in the subsequent Updates, No. 1 and No. 2, the ASRM Coronavirus/COVID-19 Task Force (the “Task Force”) recognized the need to delay any but the most urgent of reproductive care cases. This was necessary as the extent of the COVID-19 pandemic, its viral transmission rate, its impact on reproductive well-being and pregnancy, and the ability of health systems to cope were yet unknown, at least in the U.S. 

Reproductive Medical Societies Release Joint Statement on COVID-19

The three major professional societies leading infertility and reproductive medicine today issued aon providing infertility care during the on-going COVID-19 pandemic. Working together, the American Society for Reproductive Medicine (ASRM), the International Federation of Fertility Societies (IFFS), and the European Society for Human Reproduction and Embryology (ESHRE) developed the guidance document entitled COVID-19 and Human Reproduction.

ASRM Asks State Department for an International Travel Exemption for Newborns Born via Gestational Carriers During COVID-19 Pandemic

The American Society for Reproductive Medicine (ASRM) the global leader in multidisciplinary reproductive medicine research, ethical practice, and education, today sent a letter to Secretary of State Mike Pompeo requesting limited but critical exceptions to sweeping travel restrictions that have directly impacted families whose dreams of parenthood hinge on the ability to travel and connect with their surrogates. Currently, nine out of 10 people are living in countries that have closed their borders due to COVID-19.  

Advocates From 50 States to Participate in First Virtual Federal Advocacy Day

RESOLVE: The National Infertility Association and ASRM (the American Society for Reproductive Medicine) are partnering to host their annual Federal Advocacy Day as a virtual event on Wednesday, May 20, 2020. More than 400 advocates from all 50 states will meet virtually with members of Congress and their staff to discuss the physical, emotional, and financial impact of infertility and reproductive care.

ASRM Joins Amicus Briefs Opposing Abortion Restrictions in Several States

In recent weeks, a number of states have introduced measures (such as Executive Orders) to restrict access to abortion care and have justified said actions on the unique circumstances of the COVID-19 pandemic. ASRM has joined fellow national leaders and experts in the medical community – including the American College of Obstetricians and Gynecologists (ACOG) and the American Medical Association (AMA) – in opposing such restrictions by joining several amicus briefs.

Medical Society to Move Headquarters Out of Alabama

Washington, DC – The American Society for Reproductive Medicine, a major medical association celebrating its 75th anniversary this year, announced today it was moving its main headquarters from Birmingham, AL to Washington DC. The move comes in reaction to new laws in Alabama restricting access to reproductive medical services.

ReproductiveFacts.org
is a patient education website of ASRM.
 

RFSubscribe.jpg